Format

Send to

Choose Destination
See comment in PubMed Commons below
Pathologe. 2012 Nov;33 Suppl 2:269-72. doi: 10.1007/s00292-012-1664-y.

[Translational research and diagnostics in lung cancer].

[Article in German]

Author information

1
Abteilung für Prostatatkarzinom-Forschung, Institut für Pathologie, Universitätsklinikum Bonn, Bonn.

Abstract

Lung cancer is the most common malignant disease leading to death worldwide. Histologically, it is broadly subcategorized into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with the latter mainly consisting of the major entities adenocarcinoma and squamous cell carcinoma. However, molecular profiling of various lung cancer entities has revealed major molecular differences within distinct histological tumor entities, resulting in the integration of molecular alterations in the subclassification of lung cancers. These findings can only estimate the genetic complexity of lung tumors. Large scale molecular profiling has the potential to identify novel diagnostic, prognostic and predictive markers as well as therapeutic targets. Importantly, this recently arising categorization of lung carcinomas can be regarded as an example for the characterization of malignomas of other organ systems. The pioneer model for this molecular subcategorization is the classification of malignant lymphomas.

PMID:
22968733
DOI:
10.1007/s00292-012-1664-y
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center